Targeting inflammation and cytokine storm in COVID-19

被引：76

作者：

Huang, Qianwen ^{[1
]}

Wu, Xiumei ^{[1
]}

Zheng, Xueying ^{[2
]}

Luo, Sihui ^{[2
]}

Xu, Suowen ^{[2
]}

Weng, Jianping ^{[2
]}

机构：

[1] Sun Yat Sen Univ, Dept Endocrinol & Metab, Guangdong Prov Key Lab Diabetol, Affiliated Hosp 3, Guangzhou, Peoples R China

[2] Univ Sci & Technol China USTC, Dept Endocrinol, Affiliated Hosp 1, Div Life Sci & Med, Hefei, Peoples R China

来源：

PHARMACOLOGICAL RESEARCH | 2020年 / 159卷

关键词：

D O I：

10.1016/j.phrs.2020.105051

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：3

共 6 条

[1] Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19 [J].

Bao, Jinfeng ;

Li, Chenxi ;

Zhang, Kai ;

Kang, Haiquan ;

Chen, Wensen ;

Gu, Bing .

CLINICA CHIMICA ACTA, 2020, 509 :180-194

[2] The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system [J].

Coperchini, Francesca ;

Chiovato, Luca ;

Croce, Laura ;

Magri, Flavia ;

Rotondi, Mario .

CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 53 :25-32

[3] HOW DOES COVID-19 KILL? UNCERTAINTY HAMPERS DOCTORS' ABILITY TO CHOOSE TREATMENTS [J].

Ledford, Heidi .

NATURE, 2020, 580 (7803) :311-312

[4] Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury [J].

Russell, Clark D. ;

Millar, Jonathan E. ;

Baillie, J. Kenneth .

LANCET, 2020, 395 (10223) :473-475

[5] An Update on Current Therapeutic Drugs Treating COVID-19 [J].

Wu R. ;

Wang L. ;

Kuo H.-C.D. ;

Shannar A. ;

Peter R. ;

Chou P.J. ;

Li S. ;

Hudlikar R. ;

Liu X. ;

Liu Z. ;

Poiani G.J. ;

Amorosa L. ;

Brunetti L. ;

Kong A.-N. .

Current Pharmacology Reports, 2020, 6 (3) :56-70

[6]

Xie X., [No title captured]

← 1 →